Nonprescription Drugs Advisory Committee
This article was originally published in The Tan Sheet
Executive Summary
Elizabeth Connell, MD, Emory University, and Joseph Veltri, PharmD, Intermountain Regional Poison Control Center, whose terms both expired in May, have been reappointed as consultants to NDAC for one year. Thomas Petty, MD, Presbyterian/St. Luke's Medical Center, whose term also ended in May, opted not to accept a consulting position due to other commitments. Nominees to replace the three committee members are currently being considered by FDA
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning